Now showing items 1-2 of 2
Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats
(Karger Publishers Open Access, 2014-09)
Background/aims: The search for new therapies providing cardiorenal protection in chronic kidney disease (CKD) has led to treatments that combine conventional renin-angiotensin-aldosterone-system inhibitors with other drugs ...
Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice
(SAGE Publications Open Access, 2014-12)
Background—Coronary heart disease (CHD) is the number one cause of death in the US. The adipokine adiponectin has been studied intensively for presenting and inversed association with almost every stage of CHD. For instance, ...